The requirements for medicinal products do not end after packaging. Patients must be assured that the quality of their medicines is maintained throughout the supply chain. Is the medication in the hospital, from the pharmacy or from the doctor still identical to the one delivered by the manufacturer?

As a company concerned, you can ensure this with the EU Guideline on Good Distribution Practice for Medicinal Products for Human Use. In focus: distribution, safety, cold chain, packaging quality and reliable, functional technology.

• What is GDP – Good Distribution Practice?

The EU Guideline “Good Distribution Practice” is aimed at companies in the wholesale and logistics sector that work for the pharmaceutical industry. It specifies the minimum requirements that their services must meet. It also aims to minimize the risks associated with the storage and transport of medicines.

Compliance with the GDP directive ensures control of the distribution chain and thus maintains the quality and integrity of medicines. GDP requires a functioning quality management system, for example according to ISO 9001. In this way, companies can supplement the specific requirements of the GDP Guideline with little effort.